THE CLINICAL RESEARCHERS

Dr. Michael K. McGuire, DDS

Dr. Michael K. McGuire

Confidence Driven Results – And the Science to Support It

Dr. Michael McGuire puts a very high value on scientific evidence. Though a researcher, he is a clinician first and places trust in long-term data to ensure he is using materials that will help him achieve successful results for his patients. 

We took the opportunity to learn more about results of a study recently published in the Journal of Periodontology by Doctors McGuire, Scheyer and Nunn to evaluate human recession defects treated with coronally advanced flaps and either enamel matrix derivative or connective tissue, a comparison of clinical parameters at 10 years.

Read Interview


Dr. E. Todd Scheyer

Dr. E. Todd SCHEYER

Confidence Driven Results – And the Science to Support It

Dr. E. Todd Scheyer puts a very high value on scientific evidence and clinical outcomes. Although a researcher, he is a clinician first and places trust in long-term data to ensure he is using materials and protocols that will help him achieve successful and lasting results for his patients. 

We took the opportunity to learn more about results of a study recently published in the Journal of Periodontology by Doctors McGuire, Scheyer and Nunn to evaluate human recession defects treated with coronally advanced flaps and either enamel matrix derivative or connective tissue, a comparison of clinical parameters at 10 years.

Read Interview


Prof. Anton Sculean

PROF. ANTON SCULEAN

Professor Anton Sculean didn’t start out as a believer in Emdogain – in fact, he conducted a ten-year follow-up study, comparing treatment of intra-bony defects with enamel matrix proteins and/or guided tissue regeneration,1 with an aim to demonstrate the inferiority of Emdogain compared to Guided Tissue Regeneration (GTR). The study compared four treatment options (open flap debridement (OFD), Emdogain with OFD, GTR, and GTR and Emdogain) in the treatment of intrabony defects. We talked with Professor Sculean about the results of this study, why it turned him into an advocate for Emdogain and how his use of the product has changed over the last 10 years.

Read Interview